{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:21:00Z","timestamp":1791418860902,"version":"4.3.3"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.autrev.2005.04.018","type":"journal-article","created":{"date-parts":[[2005,5,24]],"date-time":"2005-05-24T12:15:39Z","timestamp":1116936939000},"page":"468-474","source":"Crossref","is-referenced-by-count":73,"title":["Anti-citrullinated protein\/peptide antibodies (ACPA) in rheumatoid arthritis: Specificity and relation with rheumatoid factor"],"prefix":"10.1016","volume":"4","author":[{"given":"B.","family":"Vander Cruyssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Peene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Cantaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.E.A.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"De Rycke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.","family":"Veys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"De Keyser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.autrev.2005.04.018_bib1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jbspin.2004.07.004","article-title":"Clinical and pathophysiological significance of the autoimmune response to citrullinated proteins in rheumatoid arthritis","volume":"71","author":"Sebbag","year":"2004","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2005.04.018_bib2","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/art.10229","article-title":"Identification of citrullinated rheumatoid arthritis-specific epitopes in natural filaggrin relevant for antifilaggrin autoantibody detection by line immunoassay","volume":"46","author":"Union","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2005.04.018_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/039463200401700202","article-title":"History and diagnostic value of antibodies to citrullinated proteins in rheumatoid arthritis","volume":"17","author":"Peene","year":"2004","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.autrev.2005.04.018_bib4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/ard.2003.008623","article-title":"Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatoid arthritis","volume":"63","author":"Dubucquoi","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2005.04.018_bib5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.7326\/0003-4819-139-3-200308050-00023","article-title":"Anti-cyclic citrullinated peptide antibodies in advanced rheumatoid arthritis","volume":"139","author":"Pinheiro","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2005.04.018_bib6","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/ard.62.9.870","article-title":"Clinical utility of the anti-CCP assay in patients with rheumatic diseases","volume":"62","author":"Lee","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2005.04.018_bib7","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/ard.2003.019877","article-title":"Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis","volume":"63","author":"Vallbracht","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2005.04.018_bib8","first-page":"2074","article-title":"Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis","volume":"29","author":"Jansen","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2005.04.018_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/03009740310004856","article-title":"Antibodies against cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early arthritis: relation to diagnosis and disease activity","volume":"33","author":"S\u00f6derlin","year":"2004","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2005.04.018_bib10","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/ard.2003.016808","article-title":"Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project)","volume":"63","author":"Kastbom","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2005.04.018_bib11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","article-title":"Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine","volume":"39","author":"Zweig","year":"1993","journal-title":"Clin Chem"},{"key":"10.1016\/j.autrev.2005.04.018_bib12","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/ard.2003.017574","article-title":"Rheumatoid factor and anti-citrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations","volume":"63","author":"De Rycke","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2005.04.018_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2004.029389","article-title":"Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis","author":"Nielen","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2005.04.018_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1373\/clinchem.2004.034728","article-title":"Diagnostic performance and predictive value of rheumatoid factor, anti-citrullinated peptide antibodies and the HLA shared epitope for the diagnosis of rheumatoid arthritis","volume":"51","author":"Hoffman","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.autrev.2005.04.018_bib15","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/ard.2004.022111","article-title":"Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus","volume":"64","author":"Hoffman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2005.04.018_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/ard.60.1.67","article-title":"Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"60","author":"Mediwake","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2005.04.018_bib17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/ard.2003.019794","article-title":"Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sj\u00f6gren's syndrome","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2005.04.018_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2004.032177","article-title":"Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis","author":"Vander Cruyssen","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2005.04.018_bib19","first-page":"511","article-title":"Antibodies to cyclic citrullinated peptides in psoriatic arthritis","volume":"32","author":"Bogliolo","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2005.04.018_bib20","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/ard.61.7.608","article-title":"Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis","volume":"61","author":"Avcin","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2005.04.018_bib21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/0891693021000014970","article-title":"Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis","volume":"35","author":"Hromadnikova","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2005.04.018_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/art.20773","article-title":"Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis","volume":"52","author":"Ferucci","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2005.04.018_bib23","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/ar1041","article-title":"Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement","volume":"6","author":"Bombardieri","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2005.04.018_bib24","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/art.20355","article-title":"Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia","volume":"50","author":"Wener","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2005.04.018_bib25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/art.10117","article-title":"How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis","volume":"46","author":"Visser","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.autrev.2005.04.018_bib26","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantapaa-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2005.04.018_bib27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2005.04.018_bib28","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1002\/art.20296","article-title":"Absence of citrulline-specific autoantibodies in animal models of autoimmunity","volume":"50","author":"Vossenaar","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2005.04.018_bib29","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/rheumatology\/39.10.1082","article-title":"Associations of rheumatoid factors and anti-filaggrin antibodies with severity of erosions in rheumatoid arthritis","volume":"39","author":"Bas","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2005.04.018_bib30","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6","article-title":"The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent onset rheumatoid arthritis","volume":"43","author":"Kroot","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2005.04.018_bib31","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/art.20316","article-title":"Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis","volume":"50","author":"van Gaalen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2005.04.018_bib32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/art.10514","article-title":"Relationship among the HLA-DRB1 shared epitope, smoking, and rheumatoid factor production in rheumatoid arthritis","volume":"47","author":"Mattey","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2005.04.018_bib33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/ar93","article-title":"Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset","volume":"2","author":"Goldbach-Mansky","year":"2000","journal-title":"Arthritis Res"},{"key":"10.1016\/j.autrev.2005.04.018_bib34","first-page":"S165","article-title":"Diagnostic performance and predictive value of serum markers and HLA shared epitope for rheumatoid arthritis (RA)","volume":"50","author":"Hoffman","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2005.04.018_bib35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/ard.2004.023523","article-title":"Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis","volume":"64","author":"De Rycke","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2005.04.018_bib36","doi-asserted-by":"crossref","DOI":"10.1007\/s00296-004-0571-9","article-title":"Antibodies against cyclic citrullinated peptides in patients affected by rheumatoid arthritis before and after infliximab treatment","author":"Caramaschi","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2005.04.018_bib37","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/ard.2003.014647","article-title":"Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement","volume":"63","author":"Alessandri","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2005.04.018_bib38","doi-asserted-by":"crossref","first-page":"R264","DOI":"10.1186\/ar1173","article-title":"Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment","volume":"6","author":"Bobbio-Pallavicini","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2005.04.018_bib39","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1002\/art.20659","article-title":"Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptide antibody","volume":"50","author":"Mikuls","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2005.04.018_bib40","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/art.11181","article-title":"Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis","volume":"48","author":"Cambridge","year":"2003","journal-title":"Arthritis Rheum"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997205000741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997205000741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T11:39:47Z","timestamp":1586259587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997205000741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S1568997205000741"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2005.04.018","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}